London, United Kingdom
Phlo, founded in 2019, is revolutionizing the pharmacy industry by offering a unique digital solution for medication delivery. Operating from the United Kingdom, Phlo leverages cutting-edge technology and analytics to ensure same-day delivery of both NHS and private prescriptions, empowering users to manage their medication needs conveniently and efficiently.
As a leader in the crossroads of Health Care, Internet, and Pharmaceutical industries, Phlo is addressing common pain points like pharmacy queues and medicine shortages, appealing to consumers who seek greater control over their healthcare experience. The digital-first approach aligns with contemporary trends towards convenience and personalization.
Recently, Phlo secured a £9.00M venture round investment on April 17, 2024, led by notable investors including Par Equity, Scottish Enterprise, and Thairm Bio. This funding reflects strong confidence in Phlo's scalable business model and its potential to grow within a rapidly evolving market.
